Role of lipid rafts and GM1 in the segregation and processing of prion protein

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Botto, Laura ^a   Cunati, Diana ^a   Coco, Silvia ^a   Sesana, Silvia ^a   Bulbarelli, Alessandra ^a   Biasini, Emiliano ^b   Colombo, Laura ^b   Negro, Alessandro ^c   Chiesa, Roberto ^b   Masserini, Massimo ^a   Palestini, Paola ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GANGLIOSIDE GD 1A; GANGLIOSIDE GM1; GANGLIOSIDE GM3; ISOPROTEIN; PRION PROTEIN; SPHINGOLIPID; LIPID BILAYER;

ANIMAL CELL; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL COMPARTMENTALIZATION; CELL SURFACE; CELLULAR DISTRIBUTION; CEREBELLUM; CIRCULAR DICHROISM; CONTROLLED STUDY; GRANULE CELL; LIPID BILAYER; LIPID RAFT; NERVE CELL; NONHUMAN; PHYSICAL CHEMISTRY; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RAT; ANIMAL; CELL MEMBRANE; CHEMISTRY; METABOLISM; PROTEIN DEGRADATION; PROTEIN SECONDARY STRUCTURE; SPRAGUE DAWLEY RAT;

ANIMALS; G(M1) GANGLIOSIDE; LIPID BILAYERS; MEMBRANE MICRODOMAINS; NEURONS; PROTEIN STRUCTURE, SECONDARY; PROTEOLYSIS; PRPC PROTEINS; PRPSC PROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84901445950     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098344     Document Type: Article

References (74)

1. Oesch B, Westaway D, Wälchli M, McKinley MP, Kent SBH, et al. (1985) A cellular gene encodes scrapie PrP 27-30 protein. Cell 40: 735-746. doi:10.1016/0092-8674(85)90333-2. (Pubitemid 15240279)
2. Biasini E, Turnbaugh JA, Unterberger U, Harris DA (2012) Prion protein at the crossroads of physiology and disease. Trends Neurosci 36: 92-103. doi:10.1016/j.tins.2011.10.002.
3. Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387: 569-572. doi:10.1038/42408. (Pubitemid 27248754)
4. Allen JA, Halverson-Tamboli RA, Rasenick MM (2007) Lipid raft micro-domains and neurotransmitter signalling. Nature, Neuroscience 8: 128-140. doi:10.1038/nrn2059. (Pubitemid 46146951)
5. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA. 95: 13363-13383. doi: 10.1073/pnas.95.23.13363.
6. Harrison PM, Bamborough P, Daggett V, Prusiner SB, Cohen FE (1997) The prion folding problem Curr. Opin. Struct. Biol. 7: 53-59. doi:10.1016/S0959- 440X(97)80007-3.
7. Donne DG, Viles JH, Groth D, Mehlhorn I, James TL, et al. (1997) Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc. Natl. Acad. Sci.USA 94: 13452-13457.
8. McKinley MP, Bolton DC, Prusiner SB (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35: 57-62. doi:10.1016/0092-8674(83)90207-6. (Pubitemid 14240218)
9. Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, et al. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73: 1339-1347. doi:10.1016/0092-8674(93)90360-3. (Pubitemid 23201147)
10. Altmeppen HC, Puig B, Dohler F, Thurm DK, Falker C, et al (2012) Proteolytic processing of the prion protein in health and disease. Am J Neurodegener Dis. 1(1):15-31.ISSN:2165-591X/AJND1204006.
11. Zulianello L, Kaneko K, Scott M, Erpel S, Han D, et al. (2000) Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein. J Virol 74: 4351-4360. doi: 10.1128/JVI.74.9.4351-4360.2000. (Pubitemid 30214443)
12. Hooper NM (2005) Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. Biochem Soc Transactions 33: 335-338. doi: 10.1042/BST0330335.
13. Endres K, Mitteregger G, Kojro E, Kretzschmar H, Fahrenholz F (2009) Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo. Neurobiol Dis36: 233-241. doi: 10.1016/j.nbd.2009.07.015.
14. Alonso DOV, An C, Daggett V (2002) Simulations of biomolecules: characterization of the early steps in the pH-induced conformational conversion of the hamster, bovine and human forms of the prion protein. Phil. Trans. R. Soc. Lond. A 360: 1165-1178 doi: 10.1098/rsta.2002.0986.
15. Riesner D (2003) Biochemistry and structure of PrP(C) and PrP(Sc). Br Med Bull 66: 21-33. doi: 10.1093/bmb/dg66.021.
16. Re F, Sesana S, Barbiroli A, Bonomi F, Cazzaniga E, et al. (2008) Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system. FEBS Lett. 582: 215-20. doi: 10.1016/j.febslet.2007.12. 003.
17. Lewis V, Hooper NM (2011) The role of lipid rafts in prion protein biology. Front Biosci. 16:151-68. doi: 10.2741/3681.
18. Goold R, Rabbanian S, Sutton L, Andre R, Arora P, et al. (2011) Rapid cell-surface prion protein conversion revealed using a novel cell system Nature communications 2:281 doi: 10.1038/ncomms1282.
19. Campana V, Sarnataro D, Fasano C, Casanova P, Paladino S, et al. (2006) Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum. J Cell Sci. 119: 433-42. doi: 10.1242/jcs.02768.
20. Gilch S, Kehler C, Schätzl HM (2006) The prion protein requires cholesterol for cell surface localization. Mol Cell Neurosci. 3: 346-53. doi:10.1016/j.mcn.2005.10.008. (Pubitemid 43214544)
21. Bremer EG, Hakomori S, Bowen-Pope DF, Raines E, Ross R (1984) Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation J Biol Chem. 259: 6818-25. (Pubitemid 14078977)
22. Mutoh T, Tokuda A, Miyadai T, Hamaguchi M, Fujiki N (1995) Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc Natl Acad Sci USA 92: 5087-91.
23. Simons M, Friedrichson T, Schulz JB, Pitto M, Masserini M, et al. (1999) Exogenous administration of gangliosides displaces GPI-anchored proteins from lipid microdomains in living cells. Mol Biol Cell 10: 3187-96. (Pubitemid 29489554)
24. Tettamanti G, Bonali F, Marchesini S, Zambotti V (1973) A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim Biophys Acta. 296: 160-170. doi: 10.1016/0005-2760(73)90055-90056.
25. Chigorno V, Palestini P, Sciannamblo M, Dolo V, Pavan A, et al. (2000) Evidence that ganglioside enriched domains are distinct from caveolae in MDCK II and human fibroblast cells in culture. Eur J Biochem 267: 4187-4197. doi: 10.1046/j.1432-1327.2000.01454.x. (Pubitemid 30436115)
26. Ghidoni R, Sonnino S, Masserini M, Orlando P, Tettamanti G (1981) Specific tritium labeling of gangliosides at the 3-position of sphingosines. J Lipid Res 22: 1286-95.
27. Botto L, Masserini M, Cassetti A, Palestini P(2004) Immunoseparation of Prion protein-enriched domains from other detergent-resistant membrane fractions, isolated from neuronal cells. FEBS Letters 557: 143-147. doi: 10.1016/S0014-5793(03)01463-7. (Pubitemid 38115885)
28. Brown DA, Rose JK (1992) Sorting of GPI-Anchored Proteins to Glycolipid-Enriched Membrane Subdomains during Transport to the Apical Cell Surface. Cell 66: 533-544. doi: 10.1016/0092-8674(92)90189-J.
29. Moore MK, Viselli SM (2000) Staining and Quantification of Proteins Transferred to Polyvinylidene Fluoride Membranes Anal Biochem. 279: 241-242. doi: 10.1006/abio.2000.4482.
30. Daffara R, Botto L, Beretta E, Conforti E, Faini A, et al. (2004) Endothelial cells as early sensors of pulmonary interstitial edema J Appl Physiol 97: 1575-1583. doi: 10.1152/japplphysiol.00236.2004. (Pubitemid 39299380)
31. Botto L, Masserini M, Palestini P (2007) Changes in the composition of detergent-resistant membrane domains of cultured neurons following protein kinase C activation. J Neurosc Res 85: 443-450. doi: 10.1002/jnr.21111. (Pubitemid 46219312)
32. Farina F, Botto L, Chinello C, Cunati D, Magni F, et al. (2009) Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture. J Neurochem 110: 1038-1048. doi: 10.1111/j.1471-4159. 2009.06198.x.
33. Laffont-Proust I, Faucheux BA, Hassig R, Sazdovitch V, Simon S, et al. (2005) The N-terminal cleavage of cellular prion protein in the human brain. FEBS Letters 579: 6333-6337. doi: org/10.1016/j.febslet.2005.10.013.
34. Zahn R, von Schroetter C, Wüthrich K (1997) Human prion proteins expressed in Escherichia coli and purified by high-affinity column refolding. FEBS Lett. 417, 400-404. http://dx.doi.org/10.1016/S0014-5793(97)01330-6 (Pubitemid 27511631)
35. Cancellotti E, Mahal PS, Somerville R, Diack A, Brown D, et al. (2013) Post-translational changes to PrP alter transmissible spongiform encephalopathy strain properties The EMBO J 32: 756-769. doi:10.1038/emboj.2013.6.
36. Lagerholm BC, Weinreb GE, Jacobson K, Thompson NL (2005) Detecting microdomains in intact cell membranes. Annu Rev Phys Chem 56: 309-336. doi 10.1146/annurev.physchem.56.092503.141211.
37. Li C, Fan Y, Lan TH, Lambert NA, Wu G (2012) Rab26 modulates the cell surface transport of a2-adrenergic receptors from the Golgi. J Biol Chem 287: 42784-42794. doi: 10.1074/jbc.M112.410936.
38. Eckert GP, Igbavboa U, Müller WE, Wood WG (2003) Lipid rafts of purified mouse brain synaptosomes prepared with or without detergent reveal different lipid and protein domains. Brain Res 962: 144-50. doi.org/10.1016/ S0006-8993(02)03986-0.
39. Walmsley AR, Watt NT, Taylor DR, Perera WS, Hooper NM (2009) Alpha-cleavage of the prion protein occurs in a late compartment of the secretory pathway and is independent of lipid rafts. Mol Cell Neurosci 40: 242-248. doi: 10.1016/j.mcn.2008.
40. Palestini P, Pitto M, Ferraretto A, Tettamanti G, Masserini M (1998) Change of ganglioside accessibility at the plasma membrane surface of cultured neurons, following protein kinase C activation. Biochemistry 37: 3143-3148. doi: 10.1021/bi971838a. (Pubitemid 28145768)
41. Ghidoni R, Riboni L, Tettamanti G (1989) Metabolism of exogenous gangliosides in cerebellar granule cells, differentiated in culture. J Neurochem 5: 1567-1574. doi: 10.1111/j.1471-4159.1989.tb08553.x. (Pubitemid 19267027)
42. Campana V, Sarnataro D, Zurzolo C (2005) The highways and byways of prion protein trafficking. TRENDS Cell Biol 15: 102-111. doi:.org/10.1016/ j.tcb.2004.12.002.
43. Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, et al. (1995) Cholesterol depletion and modification of COOH-terminal targeting sequence of the priori protein inhibit formation of the scrapie isoform. J. Biol Chem 129: 121-132. doi: 10.1083/jcb.129.1.121.
44. Marella M, Lehmann S, Grassi J, Chabry J (2002) Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release. J Biol Chem 277: 25457-25464. doi: 10.1074/jbc.M203248200. (Pubitemid 34951859)
45. Bate C, Salmona M, Diomede L, Williams A (2004) Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. J Biol Chem. 279: 14983-14990. doi: 10.1074/jbc.M313061200. (Pubitemid 38618891)
46. Naslavsky N, Shmeeda H, Friedlander G, Yanai A, Futerman AH, et al. (1999) Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions. J Biol Chem 274: 20763-20771. doi: 10.1074/jbc.274.30.20763.
47. Vincent B, Cisse MA, Sunyach C, Guillot-Sestier MV, Checler F (2008) Regulation of bAPP and PrPc cleavage by a-secretase: mechanistic and terapeutic perspectives. Cur Alzheimer Res 5: 202-211. doi: 10.2174/156720508783954749. (Pubitemid 351536345)
48. Lopez Garcia F, Zahn R, Riek R, Wuthrich K (2000) NMR structure of the bovine prion protein. Proc Natl Acad Sci 97: 8334-8339. doi: 10.1073/pnas.97.15.8334. (Pubitemid 30639673)
49. Zhang H, Stockel J, Mehlhorn I, Groth D, Baldwin MA, et al. (1997) Physical studies of conformational plasticity in a recombinant prion protein. Biochemistry 36: 3543-53 doi: 10.1021/bi961965r. (Pubitemid 27143508)
50. Hornemann S, Glockshuber R (1998) A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH. Proc Natl Acad Sci 95: 6010-6014. (Pubitemid 28248955)
51. Swietnicki W, Morillas M, Chen SG, Gambetti P, Surewicz WK (2000) Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry 39: 424-431. doi: 10.1021/bi991967m. (Pubitemid 30056478)
52. Khan MQ, Sweeting B, Mulligan VK, Arslan PE, Cashman NR, et al. (2010) Prion disease susceptibility is affected by β-structure folding propensity and local side-chain interactions in PrP. Proc Natl Acad Sci 107: 19808-19813. doi: 10.1073/pnas.1005267107.
53. C to a PrPSc-like Form*. J Biol Chem: 277:43942-43947. doi. 10.1074/jbc.M203611200.
54. Korth C, Streit P, Oesch B (1999) Monoclonal Antibodies Specific for the Native, Disease-Associated Isoform of the Prion Protein. Methods Enzymol. 309: 106-122. (Pubitemid 29446445)
55. Cordes H, Bergström AL, Ohm J, Laursen H, Heegaard PM (2008) Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues. J Immunoll Meth 337: 106-120. doi: 10.1016/j.jim.2008.07.004.
56. Kubota T, Hamazoe Y, Hashiguchi S, Ishibashi D, Akasaka K, et al. (2012) Direct Evidence of Generation and Accumulation of β-Sheet-rich Prion Protein in Scrapie-infected Neuroblastoma Cells with Human IgG1 Antibody Specific for β-Form Prion Protein. J Biol Chem. 287: 14023-14039. doi. 10.1074/jbc.M111.318352.
57. Kupfer L, Hinrichs W, Groschup MH (2009) Prion Protein misfolding. Curr Mol Med. 9: 826-835. doi: 10.2174/156652409789105543.
58. Jeong JK, Moon MH, Lee YJ, Seol JW, Park SY (2012) Translocation of cellular prion protein to non-lipid rafts protects human prion-mediated neuronal damage. Int J Mol Med. 29: 387-392. doi: 10.3892/ijmm.2011.864.
59. Prinetti A, Chigorno V, Tettamanti G, Sonnino S (2000) Sphingolipid-enriched membrane domains from rat cerebellar granule cells differentiated in culture J Biol Chem. 275: 11658-11665. doi 10.1074/jbc.275.16.11658.
60. Morris RJ, Parkyn CJ, Jen A (2006) Traffic of prion protein between different compartments on the neuronal surface, and the propagation of prion disease. FEBS Lett. 9; 580:5565-5571. doi: org/10.1016/j.febslet.2006.07.053.
61. Gonatas NK, Stieber A, Gonatas J, Mommoi T, Fishman PH (1983) Endocytosis of exogenous GM1 ganglioside and cholera toxin by neuroblastoma cells. Mol Cell Biol 3: 91-101. doi: 10.1128/MCB.3.1.91. (Pubitemid 13194436)
62. Palestini P, Pitto M, Tedeschi G, Ferraretto A, Parenti M, et al. (2000) Tubulin anchoring to glycolipid-enriched, detergent-resistant domains of the neuronal plasma membrane. J Biol Chem 275: 9978-9985. doi: 10.1074/jbc.275.14. 9978. (Pubitemid 30202044)
63. Yamasaki T, Suzuki A, Shimizu T, Watarai M, Hasebe R, et al. (2012) Characterization of intracellular localization of PrPSc in prion-infected cells using a mAb that recognizes the region consisting of aa 119-127 of mouse PrP. J Gen Virol93: 668-680 doi 10.1099/vir.0.037101-0.
64. Enari M, Flechsig E, Weissmann C (2001) Scrapie prion protein accumulation by scrapieinfected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci: 98: 9295-9299. doi. 10.1073/pnas 151242598.
65. Sanghera N, Correia BE, Correia JR, Ludwig C, Agarwal S, et al. (2011) Deciphering the molecular details for the binding of the prion protein to main ganglioside GM1 of neuronal membranes. Chem Biol 18: 1422-1431. doi: 10.1016/j.chembiol.2011.
66. Simons M, Friedrichson T, Schulz JB, Pitto M, Masserini M, et al. (1999) Exogenous administration of gangliosides displaces GPI-anchored proteins from lipid microdomains in living cells. Mol Biol Cell 10(10):3187-96. (Pubitemid 29489554)
67. Chigorno V, Palestini P, Sciannamblo M, Dolo V, Pavan A, et al. (2000) Evidence that ganglioside enriched domains are distinct from caveolae in MDCK II and human fibroblast cells in culture. Eur J Biochem 267(13):4187- 4197. doi: 10.1046/j.1432-1327.2000.01454.x
68. Joseph KC, Stieber A, Gonatas NK (1979) Endocytosis of cholera toxin in GERL-like structures of murine neuroblastoma cells pretreated with GM1 ganglioside. J Biol Chem 81:543-554.
69. Biljan I, Ilc G, Giachin G, Plavec J, Legname G (2012) Structural Rearrangements at Physiological pH: Nuclear Magnetic Resonance Insights from the V210I Human Prion Protein Mutant. Biochemistry 51 (38): 7465-7474 doi: 10.1021/bi3009856.
70. Vila-Vicosa D, Campos SRR, Baptista AM, Machuqueiro M (2012) Reversibility of Prion misfolding: insights from constant-pH molecular dynamics simulations. J Phys Chem B116: 8812-8821. doi.org/10.1021/jp3034837.
71. Castilla J, Goni FM (2011) Lipids, a Missing Link in Prion Propagation. Chemistry & Biology 18 Issue 11: 1345-1346 doi: 10.1016/j.chembiol.2011.11. 002
72. Matsuzaki K, Horikiri C (1999) Interactions of amyloid alfa-peptide (1-40) with ganglioside-containing membranes. Biochemistry 38: 4137-4142. doi 10.1002/prot.22853.
73. Choo-Smith LP, Garzon-Rodriguez W, Glabe CG, Surewicz WK (1997) Acceleration of amyloid fibril formation by specific binding of A b-(1-40) peptide to ganglioside-containing membrane vesicles. J Biol Chem 272: 22987-22990. doi: 10.1177/1073858405275177. (Pubitemid 27392420)
74. Kakio A, Nishimoto S, Kozutsumi Y, Matsuzaki K (2003) Formation of a membrane-active form of amyloid â-protein in raft-like model membranes. Biochem Biophys Res Commun 303: 514-518. doi:10.1016/j.chemphyslip. 2008.12.001.